Both receptors recognize CD155 (also known as PVR) and CD112 (also known as Nectin-2), ubiquitous cell-adhesion molecules (167) overexpressed in HER2+ breast cancer cell lines (51). The gene discussed is ERBB2; the disease is breast carcinoma.